PMV Pharmaceuticals' Cash Burn: Assessing Its Growth Potential

PMV Pharmaceuticals (NASDAQ:PMVP) had $142m in cash and was debt-free in June 2025. The company burnt through $70m in the last year, giving it a cash runway of about 2.0 years. While its cash burn increased 51% over the last 12 months, its solid cash runway and potential for growth may make it easier to raise more capital. However, investors should consider the risks associated with unprofitable companies and the possibility of cash burn leading to a collapse.